Advanced glycation endproducts and their receptor: Do they play a role in diabetic cardiomyopathy?

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 10, 2002, Pages 1305-1308

  Arai, Masashi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCIUM ION; GENE PRODUCT; GLUCOSE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN SERCA2; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARDIOMYOPATHY; CORRELATION ANALYSIS; DIABETES MELLITUS; EDITORIAL; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; NOTE;

ANIMALS; CALCIUM-TRANSPORTING ATPASES; CARDIOMYOPATHIES; DIABETES COMPLICATIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; RECEPTORS, IMMUNOLOGIC; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 0036772588     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(02)92097-3     Document Type: Editorial

References (31)

1. Ahmed SS, Jaferi GA, Narang RM, Regan TJ. Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J 1975; 89: 153-158.
2. Dhalla NS, Liu X, Panagia V, Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 1998; 40: 239-247.
3. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II: Potential mechanisms. Circulation 2002; 105: 1861-1870.
4. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 1992; 258: 766-770.
5. Duplus E, Glorian M, Forest C. Fatty acid regulation of gene transcription. J Biol Chem 2000; 275: 30749-30752.
6. 2+-ATPase improves mvocardial contractility in diabetic cardiomyopathy. Diabetes 2002; 51: 1166-1171.
7. Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H, Tsuji T, Kohzuki H, Suga H, Taniguchi S, Takaki M. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol 2002; 282: H138-H148.
8. Zhong Y, Ahmed S, Grupp IL, Matlib MA. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol 2001; 281: H1137-H1147.
9. 2+Channel mRNA in streptozotocin-induced diabetic rat heart. J Mol Cell Cardiol 2000; 32: 655-664.
10. 2+ overload. J Physiol 2000; 527: 85-94.
11. 2+-ATPase activity and phosphorylation level of phospholamban. Am J Physiol 1999; 277: H474-H480.
12. 2+-ATPase gene transcription. Circ Res 2000; 86: 8-14.
13. Vaulont S, Vasseur-Cognet M, Kahn A. Glucose regulation of gene transcription. J Biol Chem 2000; 275: 31555-31558.
14. Daniel S, Kim KH. Sp1 mediates glucose activation of the acetyl-CoA carboxylase promoter. J Biol Chem 1996; 271: 1385-1392.
15. Schafer D, Hamm-Kunzelmann B, Brand K. Glucose regulates the promoter activity of aldolase A and pyruvate kinase M2 via dephosphorylation of Sp1. FEBS Lett 1997; 417: 325-328.
16. Chen YQ, Su M, Walia RR, Hao Q, Covington JW, Vaughan DE. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J Biol Chem 1998; 273: 8225-8231.
17. Sayeski PP, Kudlow JE. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription. J Biol Chem 1996; 271: 15237-15243.
18. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes. Am J Physiol 1999; 277: E1-E10.
19. Doiron B, Cuif MH, Chen R, Kahn A. Transcriptional glucose signaling through the glucose response element is mediated by the pentose phosphate pathway. J Biol Chem 1996; 271: 5321-5324.
20. Nishimura M, Uyeda K. Purification and characterization of a novel xylulose 5-phosphate-activated protein phosphatase catalyzing dephosphorylation of fructose-6-phosphate, 2-kinase: Fructose-2. 6-bisphosphatase. J Biol Chem 1995; 270: 26341-26346.
21. Han I, Kudlow JE. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol Cell Biol 1997; 17: 2550-2558.
22. 2+-ATPase gene. J Biol Chem 1990; 265: 4670-4677.
23. 2+-TPase gene promoter are required for expression in Sol8 muscle cells. J Biol Chem 1996; 271: 5921-5928.
24. Takizawa T, Arai M, Yoguchi A, Tomaru K, Kurabayashi M, Nagai R. Transcription of the SERCA2 gene is decreased in pressure-overloaded hearts: A study using in vivo direct gene transfer into living myocardium. J Mol Cell Cardiol 1999; 31: 2167-2174.
25. Osborne TF. Sterol regulatory element-binding proteins (SREBPs): Key regulators of nutritional homeostasis and insulin action. J Biol Chem 200; 275: 32379-32382.
26. 2+-ATPase (SERCA2) gene. Nucleic Acids Res 1998; 26: 1092-1098.
27. Schmidt AM, Yan SD, Stern DM. The dark side of glucose. Nat Med 1995; 1: 1002-1004.
28. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999; 84: 489-497.
29. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J Biol Chem 1997; 272: 17810-17814.
30. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994; 269: 9889-9897.
31. 2+-ATPase function by direct attack on the ATP binding site. Circ Res 1997; 80: 76-81.